Lemaitre Vascular LMAT
NASDAQ LMAT
$78.74 -0.73 (-0.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Lemaitre Vascular (LMAT) Other Non-Current Assets (2010 - 2026)

Lemaitre Vascular's (LMAT) quarterly Other Non-Current Assets came in at $5.4 million in Q2 2026, up 7.92% year-over-year from $5.0 million in Q2 2025, and up 9.46% quarter-over-quarter from $5.0 million in Q1 2026.

Analysis

Lemaitre Vascular (LMAT) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has reported Other Non-Current Assets for 17 consecutive years, with $5.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets rose 7.92% year-over-year to $5.4 million in Q2 2026; TTM through Jun 2026 was $5.4 million, a 7.92% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, up 0.78% from the prior year.
  • Other Non-Current Assets was $5.4 million for Q2 2026 at Lemaitre Vascular, up from $5.0 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $5.4 million in Q2 2026 and troughed at $556000.0 in Q1 2022.
  • A 5-year average of $3.5 million and a median of $4.1 million in 2024 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets sank 49.91% in 2022 and jumped 277.4% in 2023, its largest moves.
  • Over 5 years, Other Non-Current Assets stood at $991000.0 in 2022, then jumped by 277.4% to $3.7 million in 2023, then surged by 30.16% to $4.9 million in 2024, then rose by 0.78% to $4.9 million in 2025, then climbed by 10.88% to $5.4 million in 2026.
  • The last three Other Non-Current Assets figures came in at $5.4 million (Q2 2026), $5.0 million (Q1 2026), and $4.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn -
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 4.32 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 3.23 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 616.40 Mn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 434.00 Mn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 273.70 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 215.10 Mn
10 Lemaitre Vascular 1.80 Bn 1.43 Bn 50.76 Mn 5.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.44 Mn
Mar 31, 2026 4.97 Mn
Dec 31, 2025 4.91 Mn
Sep 30, 2025 5.03 Mn
Jun 30, 2025 5.04 Mn
Mar 31, 2025 5.17 Mn
Dec 31, 2024 4.87 Mn
Sep 30, 2024 4.23 Mn
Jun 30, 2024 4.12 Mn
Mar 31, 2024 4.01 Mn
Dec 31, 2023 3.74 Mn
Sep 30, 2023 3.15 Mn
Jun 30, 2023 2.93 Mn
Mar 31, 2023 2.07 Mn
Dec 31, 2022 991,000.00
Sep 30, 2022 973,000.00
Jun 30, 2022 984,000.00
Mar 31, 2022 556,000.00
Dec 31, 2021 568,000.00
Sep 30, 2021 994,000.00